title: Reply to Hartjen et al.
authors.forename: Sarah
authors.initials: S
authors.lastname: Boudova
authors.forename: Haishan
authors.initials: H
authors.lastname: Li
authors.forename: Mohammad M
authors.initials: MM
authors.lastname: Sajadi
authors.forename: Robert R
authors.initials: RR
authors.lastname: Redfield
authors.forename: Cristiana
authors.initials: C
authors.lastname: Cairo
authors.forename: C
authors.initials: C
authors.lastname: David Pauza
mesh_terms: D005260:Female; D006678:HIV / Q000502:physiology*; D015658:HIV Infections / Q000276:immunology*; D006801:Humans; D008297:Male; D016692:Receptors, Antigen, T-Cell, gamma-delta / Q000276:immunology*; D013601:T-Lymphocytes / Q000276:immunology*; D014779:Virus Replication
chemical_list: D016692:Receptors, Antigen, T-Cell, gamma-delta
references.citation: BMC Immunol. 2009 Sep 21;10:50
references.pmid: 19772585
references.citation: J Infect Dis. 2012 May 1;205(9):1448-55
references.pmid: 22454465
references.citation: Expert Opin Biol Ther. 2008 Jul;8(7):875-83
references.pmid: 18549319
references.citation: Clin Infect Dis. 2008 May 1;46(9):1466-72
references.pmid: 18419457
references.citation: Blood. 2010 Nov 18;116(20):4148-57
references.pmid: 20660793
references.citation: AIDS. 2009 Sep 24;23(15):1955-64
references.pmid: 19609200
references.citation: J Immunol. 2002 Feb 1;168(3):1484-9
references.pmid: 11801693